TEM Tempus AI, Inc.
Company Analysis
Latest News
🟢 Tempus AI is trading 4.2% up — catalyst remains unclear
Tempus AI is trading 4.2% higher at $86.05, with no confirmed catalyst for the move. - No new company announcement on September 30 clearly explains the rise;...
Tempus AI Secures FDA Clearance for Mitral Regurgitation Screening Tool
Tempus AI received U.S. Food and Drug Administration (FDA) clearance for ECG-MR AI, an algorithm that analyzes electrocardiograms (ECGs) to identify patients...
🟢 Tempus AI is trading 4.6% up today despite broader U.S. market declines
Tempus AI is trading higher despite broader U.S. markets moving lower on September 24, 2026; no company-specific catalyst was identified. - Trading at $80.09...
Goldman Sachs Upgrades Tempus AI to 'Hold' Amid Mixed Analyst Sentiment
The Goldman Sachs Group upgraded Tempus AI (TEM) to "Hold" from "Neutral." Overall analyst sentiment for the precision medicine company remains mixed. The...
Tempus AI's Growth Trajectory and AI Expansion Highlighted in Positive Analyst Review
Seeking Alpha reiterated a buy rating for Tempus AI on September 22, 2026, citing a 60% rally since its last analysis. The report highlighted robust growth in...
Tempus AI Secures $42M Recursion Deal Extension, Goldman Sachs Initiates Neutral
Tempus AI extended its data license agreement with Recursion Pharmaceuticals through November 2029. The amended contract guarantees $42 million in committed...
🔴 Tempus AI is trading 4.1% down today after a 14.85% gain on September 17
Tempus AI is trading 4.1% down at $77.08, with no clear negative company-specific catalyst identified for September 18, 2026. - The decline follows a sharp...
Tempus AI Shares Surge 35%, Driven by Expanded Merck Partnership
Tempus AI shares climbed approximately 35.5% over the last 30 days, including a significant surge this week. A technical short squeeze further amplified the...
🟢 Tempus AI is trading 10.7% up today amid broad market rally
Tempus AI is trading at $78.14, up 10.66%, alongside a broad September 17, 2026 market rally. - Nasdaq is up 1.30%, while the S&P 500 is up 0.86%. - No new...
Tempus AI Surges 10% on Morgan Stanley Growth Pitch — But Can the Stock Sustain a Price Already Above Wall Street's Average Target?
Shares jumped as CEO Eric Lefkofsky took the stage at the Morgan Stanley 24th Annual Global Healthcare Conference on September 15, painting an aggressive...
🟢 Tempus AI Jumps 10.35% on Piper Sandler Upgrade, Personalis Acquisition Optimism, and Strong Q2 Results
Tempus AI is trading 10.35% up now at $68.65, driven by several key catalysts today: Piper Sandler upgraded Tempus AI to Overweight, raising its price...
🟢 Tempus AI is trading 4.77% up today after Morgan Stanley conference highlights on diagnostics growth
Tempus AI is trading $65.18, 4.77% up after its September 15, 2026 appearance at the Morgan Stanley 24th Annual Global Healthcare Conference, where management...
🟢 Tempus AI rises 4.1% — Software Stocks Surge on Tech Sector Rotation Away From AI Hardware
With Software (IGV) up 3.1%, this looks like a sector-led move rather than a company-specific surprise. Software stocks are rallying as investors rotate...
Tempus AI builds 100,000-genome database, accelerating AI-driven medical research
Tempus AI (NASDAQ: TEM) launched a multiyear initiative to build a research platform featuring 100,000 whole genomes. This dataset links genomic data to...
🔴 Tempus AI is trading 4.1% down today as August producer inflation pressured rate-sensitive stocks
Tempus AI is trading 4.1% down at $58.77 as August producer inflation exceeded expectations, pressuring rate-sensitive technology and healthcare stocks. -...
Tempus AI wins $9.5M federal grant for autonomous heart failure care
Tempus AI secured up to $9.5 million from the Advanced Research Projects Agency for Health (ARPA-H). The award is part of the U.S. Department of Health and...
🔴 Tempus AI is trading 4.2% down today amid Nasdaq weakness and oil surging toward $100
Tempus AI is trading 4.2% down at $61.56 amid broad market weakness and heightened geopolitical risk on September 9, 2026. - The Nasdaq Composite is down...
🟢 Tempus AI is trading 4.1% up today as software stocks rally
Tempus AI is trading 4.1% up at $64.46, alongside strong gains across software stocks. - The sector rally has been supported by Snowflake’s...
🟢 Tempus AI is trading 5.4% up today after Cantor Fitzgerald initiated coverage with Overweight rating
Tempus AI is trading 5.4% up now at $65.63 after Cantor Fitzgerald initiated coverage on September 2, 2026, with an Overweight rating and an $80 price...
Tempus AI eyes $80 target, Cantor cites undervalued platform potential
Cantor Fitzgerald initiated coverage of Tempus AI, Inc. with an overweight rating. The firm set a price target of $80.00 for the company. Analysts believe...